Your browser doesn't support javascript.
loading
TAK1 is a druggable kinase for diffuse large B-cell lymphoma.
Wu, Yuanyuan; Yang, Riyun; Ming, Yue; Xu, Yuanpei; Chen, Hao; Yao, Min; Chen, Xia; Mao, Renfang; Fan, Yihui.
Afiliación
  • Wu Y; Basic Medical Research Center, School of Medicine, Nantong University, Nantong, China.
  • Yang R; Basic Medical Research Center, School of Medicine, Nantong University, Nantong, China.
  • Ming Y; Department of Immunology, School of Medicine, Nantong University, Nantong, China.
  • Xu Y; Department of Immunology, School of Medicine, Nantong University, Nantong, China.
  • Chen H; Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, China.
  • Yao M; Department of Immunology, School of Medicine, Nantong University, Nantong, China.
  • Chen X; Basic Medical Research Center, School of Medicine, Nantong University, Nantong, China.
  • Mao R; Department of Pathophysiology, School of Medicine, Nantong University, Nantong, China.
  • Fan Y; Basic Medical Research Center, School of Medicine, Nantong University, Nantong, China.
Cell Biochem Funct ; 37(3): 153-160, 2019 Apr.
Article en En | MEDLINE | ID: mdl-30907011
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Quinasas Quinasa Quinasa PAM / Terapia Molecular Dirigida Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Biochem Funct Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Quinasas Quinasa Quinasa PAM / Terapia Molecular Dirigida Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Biochem Funct Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido